BROOKS vs UNICHEMLAB: Stock Comparison
BROOKS LAB is the larger company by market capitalisation. BROOKS LAB shows a lower P/E, a higher ROE and a higher net margin, while UNICHEM LABORATORIES shows faster revenue growth, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
BROOKS leads 6; UNICHEMLAB leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | BROOKS | UNICHEMLAB |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | BROOKS | UNICHEMLAB |
|---|---|---|
| Live Price | ₹69.46 | ₹530.9 |
| Day Change | 18.17% | -2.8% |
| Volume | 15.09 L | 1.64 L |
| 52-Week High | ₹131.9 | ₹687.2 |
| 52-Week Low | ₹36.3 | ₹278.2 |
| Distance from 52W High | -47.34% | -22.74% |
Valuation
| Metric | BROOKS | UNICHEMLAB |
|---|---|---|
| Market Cap | ₹20,461 L Cr | ₹3,698 Cr |
| P/E Ratio | 8.22x | 12.13x |
| P/B Ratio | 1.65x | 1.36x |
| EPS | ₹4.49 | ₹0.79 |
| Book Value | ₹41.64 | ₹385.97 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | BROOKS | UNICHEMLAB |
|---|---|---|
| Revenue Growth (TTM YoY) | -6.37% | -2.1% |
| EPS Growth (TTM YoY) | 0% | -79.3% |
| Qtr Sales Growth | 0% | -42.1% |
| Qtr Profit Growth | -225.96% | -86.67% |
Profitability & Leverage
| Metric | BROOKS | UNICHEMLAB |
|---|---|---|
| ROE | 20.04% | 6.05% |
| ROCE | 5.38% | 9.11% |
| Net Margin | 28.67% | 11.48% |
| Operating Margin | 7.74% | 15.66% |
| Debt to Equity | 0.06x | 0.02x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | BROOKS | UNICHEMLAB |
|---|---|---|
| Promoter Holding | 52.62% | 70.22% |
| FII Holding | 0%▼ 0.17 pp | 0.9%▼ 0.1 pp |
| DII Holding | 10.38% | 10.46%▼ 0.17 pp |
| Public Holding | 37%▲ 0.16 pp | 18.42%▲ 0.27 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BROOKS LAB and UNICHEM LABORATORIES.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.